IL136720A0 - Indole derivatives useful a.o. for the treatment of osteoporosis - Google Patents

Indole derivatives useful a.o. for the treatment of osteoporosis

Info

Publication number
IL136720A0
IL136720A0 IL13672098A IL13672098A IL136720A0 IL 136720 A0 IL136720 A0 IL 136720A0 IL 13672098 A IL13672098 A IL 13672098A IL 13672098 A IL13672098 A IL 13672098A IL 136720 A0 IL136720 A0 IL 136720A0
Authority
IL
Israel
Prior art keywords
osteoporosis
treatment
indole derivatives
derivatives useful
useful
Prior art date
Application number
IL13672098A
Other languages
English (en)
Original Assignee
Smithkline Beecham Lab
Smithkline Beecham Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Lab, Smithkline Beecham Spa filed Critical Smithkline Beecham Lab
Publication of IL136720A0 publication Critical patent/IL136720A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13672098A 1997-12-24 1998-12-17 Indole derivatives useful a.o. for the treatment of osteoporosis IL136720A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97403154 1997-12-24
PCT/EP1998/008561 WO1999033822A1 (en) 1997-12-24 1998-12-17 Indole derivatives useful a.o. for the treatment of osteoporosis

Publications (1)

Publication Number Publication Date
IL136720A0 true IL136720A0 (en) 2001-06-14

Family

ID=8229937

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13672098A IL136720A0 (en) 1997-12-24 1998-12-17 Indole derivatives useful a.o. for the treatment of osteoporosis

Country Status (23)

Country Link
EP (1) EP1042316B1 (es)
JP (1) JP4627881B2 (es)
KR (1) KR20010033528A (es)
CN (1) CN1208333C (es)
AR (1) AR018032A1 (es)
AT (1) ATE288909T1 (es)
AU (1) AU749319B2 (es)
BR (1) BR9814403A (es)
CA (1) CA2315723A1 (es)
CO (1) CO4970811A1 (es)
DE (1) DE69828998T2 (es)
ES (1) ES2236971T3 (es)
HK (1) HK1032953A1 (es)
HU (1) HUP0100785A3 (es)
IL (1) IL136720A0 (es)
NO (1) NO320272B1 (es)
NZ (1) NZ505060A (es)
PL (1) PL191633B1 (es)
SA (1) SA99200109B1 (es)
SI (1) SI1042316T1 (es)
TR (1) TR200001992T2 (es)
WO (1) WO1999033822A1 (es)
ZA (1) ZA9811758B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914371D0 (en) 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
GB9914825D0 (en) 1999-06-24 1999-08-25 Smithkline Beecham Spa Novel compounds
ES2325477T3 (es) * 2000-03-31 2009-09-07 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indoles sustituidos por fenilo como antagonistas del receptor de histamina h3.
ATE361297T1 (de) 2000-03-31 2007-05-15 Ortho Mcneil Pharm Inc Phenyl-substituierte imidazopyridine
US6872834B2 (en) 2000-03-31 2005-03-29 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituted indoles and indazoles
ITMI20040875A1 (it) * 2004-04-30 2004-07-30 Ist Naz Stud Cura Dei Tumori Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali
US20090142832A1 (en) * 2007-11-29 2009-06-04 James Dalton Indoles, Derivatives, and Analogs Thereof and Uses Therefor
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
PL3209655T3 (pl) 2014-10-24 2020-12-28 Landos Biopharma, Inc. Leczenie oparte na białku 2 podobnym do syntetazy lantioniny C
MX2020005525A (es) 2017-11-30 2020-10-28 Landos Biopharma Inc Tratamientos con ligandos de proteína 2 similar a lantionina c y células preparadas con estos.
CA3135502C (en) 2019-12-20 2024-01-09 Josep Bassaganya-Riera Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3542827B2 (ja) * 1994-07-15 2004-07-14 帝国臓器製薬株式会社 新規な5−置換イソキサゾール−3−カルボン酸アミド誘導体
JPH10512251A (ja) * 1995-01-10 1998-11-24 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ 骨粗鬆症の治療に有用なインドール誘導体
KR20010014030A (ko) * 1997-06-19 2001-02-26 더글라스이.리디치 퀴놀린-인돌 항균제, 이들의 용도 및 조성물
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto

Also Published As

Publication number Publication date
ES2236971T3 (es) 2005-07-16
ATE288909T1 (de) 2005-02-15
TR200001992T2 (tr) 2001-01-22
SI1042316T1 (es) 2005-08-31
JP4627881B2 (ja) 2011-02-09
DE69828998D1 (de) 2005-03-17
CO4970811A1 (es) 2000-11-07
PL191633B1 (pl) 2006-06-30
ZA9811758B (en) 2000-06-22
NO20003315L (no) 2000-06-23
NZ505060A (en) 2002-09-27
WO1999033822A1 (en) 1999-07-08
KR20010033528A (ko) 2001-04-25
PL341318A1 (en) 2001-04-09
HUP0100785A2 (hu) 2001-08-28
AU2715499A (en) 1999-07-19
CN1299357A (zh) 2001-06-13
CN1208333C (zh) 2005-06-29
NO20003315D0 (no) 2000-06-23
BR9814403A (pt) 2000-10-10
NO320272B1 (no) 2005-11-14
HK1032953A1 (en) 2001-08-10
SA99200109B1 (ar) 2006-09-13
AU749319B2 (en) 2002-06-20
CA2315723A1 (en) 1999-07-08
EP1042316A1 (en) 2000-10-11
DE69828998T2 (de) 2006-05-04
HUP0100785A3 (en) 2001-09-28
AR018032A1 (es) 2001-10-31
EP1042316B1 (en) 2005-02-09
JP2003532616A (ja) 2003-11-05

Similar Documents

Publication Publication Date Title
ZA988078B (en) Substituted oxindole derivatives.
ZA9811898B (en) Anti-Inflammatory Compounds.
ZA98970B (en) N-hydroxy-ß-sulfonyl propionamide derivatives.
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
GB9700504D0 (en) Pharmaceutical compounds
AU1139095A (en) Combination treatment for osteoporosis
HU9801168D0 (en) Triazinylaminostilbene derivatives
ZA961697B (en) Indole derivatives.
GB9908648D0 (en) Substituted thienobenzisoxazole derivatives for enhancing cognition
EP1003495A4 (en) PHARMACEUTICAL COMPOUNDS
GB9926537D0 (en) Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds
GB9716244D0 (en) Pharmaceutical compounds
ZA973209B (en) Therapeutic compounds.
HK1032953A1 (en) Indole derivatives useful a.o. for the treatment of osteoporosis.
ZA9810033B (en) Process for the preparation of Thiazolidinedione Derivatives.
ZA974811B (en) Novel therapeutic compounds.
ZA982436B (en) Thiazolimine derivatives.
CY2392B1 (en) Method for the preparation of alpha-bromolactam derivatives.
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
GB9908644D0 (en) Substituted thienylcyclohexanone derivatives for enhancing cognition
ZA982255B (en) Process for the preparation of arylmalonates.
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
HUP0001751A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
ZA98300B (en) Pharmaceutical compounds